# Clinical Launch Review & Regulatory Stance

## Overview
PathoMatch has been fundamentally engineered for raw performance, deterministic accuracy, and absolute data privacy. This document outlines the clinical readiness of the platform.

## 1. Accuracy and Safety Profile
- **Deterministic Biology:** The biological analysis relies completely on standard dynamic programming (Smith-Waterman). It does not hallucinate sequences or binding energies. 1+1 always equals 2.
- **AI Safety Auditor:** The LLM translation pipeline is guarded by a heuristic Safety Auditor. If the LLM generates a treatment protocol that contradicts the retrieved clinical context, the auditor intercepts and flags the report.
- **No Cloud Data Leaks:** Because the system operates entirely on local hardware (Ollama + local Vector DB), patient EHR data and genome sequences are never transmitted to third-party APIs (e.g., OpenAI). This ensures implicit data security.

## 2. Regulatory Stance & FDA Status
*Note: This platform has been developed with a focus on cutting-edge research capability rather than navigating bureaucratic tape.*

- **Research Use Only (RUO):** At launch, PathoMatch is designated strictly as a "Research Use Only" tool. It is not an FDA-approved diagnostic medical device. 
- **Decision Support, Not Diagnosis:** The tool is designed to provide *clinical decision support* to trained oncologists, pathologists, and veterinarians. The final medical decision must always rest with the licensed physician.
- **Liability Disclaimer:** Users must acknowledge that the software translates and aligns data, but does not legally prescribe medicine.

## 3. Operational Readiness
The codebase has been strictly audited to ensure:
- Zero memory leaks during heavy sequence chunking.
- Graceful degradation on low VRAM (8GB) hardware.
- Seamless bridging between the React frontend, the FastAPI backend, the Mathematical Engine, and the Local LLM.

**Status:** BETA-READY for clinical research environments.
